Supernus Pharmaceuticals | SUPN - أصول متداولة





أصول متداولة تغيير تاريخ
Abbott USD 25.51B 488M 2026-03
ANI Pharmaceuticals USD 747.08M 6.03M 2026-03
Aurora Cannabis CAD 397.45M 48.38M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Canopy Growth CAD 529.47M 4.8M 2026-03
Cara Therapeutics USD 31.54M 6.9M 2025-12
Corcept Therapeutics USD 426.03M 59.43M 2026-03
Eisai JPY 761.64B 79.24B 2026-03
Eli Lilly USD 54.84B 794M 2026-03
Novo Nordisk DKK 177.32B 4.86B 2026-03
Pacira USD 514.96M 33.01M 2026-03
Perrigo USD 2.71B 85M 2026-03
Pfizer USD 42.82B 76M 2026-03
Supernus Pharmaceuticals USD 731.58M 87.4M 2026-03
United Therapeutics USD 2.87B 830.5M 2026-03
Xeris Pharmaceuticals USD 251.68M 11.37M 2026-03